Advertisement

Lessons from one year experience of pooled procurement of pharmaceuticals: exploration of indicators and assessing pharmacies` performance

  • Peivand Bastani
  • Mohammad Hadi Imanieh
  • Hesam Dorosti
  • Reza Abbasi
  • Seyyed Alireza Dashti
  • Khosro KeshavarzEmail author
Research Article
  • 129 Downloads
Part of the following topical collections:
  1. The Human Right to Access to Medicines

Abstract

Background

Joint procurement of medicines is a way to improve access and justice in developing countries. The aim of this study is to determine local indicators for assessing the performance of joint procurement agencies and compare the indicators in those pharmacies which use centralized purchasing before and after this change.

Methods

This was a mixed method study. In the first qualitative phase, 3 expert panels were held including 20 national experts who were selected through purposeful sampling. Data was analyzed applying a five-stage framework analysis using MAXQDA. In the second quantitative phase, financial, supply and procurement, physical and functional indicators of two hospitals affiliated with joint procurement were assessed and the satisfactions of patients from the pharmacy performance were compared applying a valid questionnaire. Data was analyzed using SPSS through independent test, Paired t-test and ANOVA.

Results

Results show that after settlement of joint procurement, the cost of transportation has increased by 54%, a part of the cost of overhead has increased by 30%, the cost of manpower has increased by 88.9% and cost of insurance of warehouses has increased by 71.85% in 2016 compared to 2015. In addition, the total costs of holding were 89.8% of selling revenue. In other words, the profit was about 10% of revenue in total. Moreover the average score of pharmacies under the Holding has been higher than similar ones in all aspects of satisfaction from the patients` points of view.

Conclusion

The one-year experience of deploying centralized purchasing to supply medicine has led to increased income and patient satisfaction. However, increase in staffing costs, longevity, overhead and warehouse costs have been significant that need appropriate monitoring and interventions.

Graphical abstract

Graphical abstract of lessons from one year experience of pooled procurement of pharmaceuticals in south of Iran

Keywords

Pharmaceutical holding Pooled procurement Joint procurement Centralized purchasing Indicators 

Notes

Acknowledgements

This Manuscript is retrieved from MSc thesis that was supported and approved by Shiraz University of Medical Sciences with the ID number of 95-01-07-11582. The research proposal was approved by ethics committee of Shiraz University of Medical Sciences with the ID number of IR.Sums.Rec.1395.s361.

Author contributions

PB: Study concept and design, participated in literature bibliography, Acquisition of data, Analysis and interpretation of data, Drafting of the manuscript, Critical revision of the manuscript for important intellectual content. MHI: Participate in design of study and drafting of the manuscript. HD: Participate in design of study, Drafting of the manuscript and, Acquisition of data. RA: participated in literature bibliography and collecting clinical data, Analysis and interpretation of data. SAD: Acquisition of data, Participate in design of study. KHK: Participate in design of study and drafting of the manuscript, and final revision of the manuscript. All authors read and approved the final manuscript.

Compliance with ethical standards

Conflicts of interest

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

The study was approved by ethics committee of Shiraz University of Medical Sciences with the ID number of IR.Sums.Rec.1395.s361.

References

  1. 1.
    Gh M, Bastani P. Pharmaceutical strategic purchasing: a key to improve access to medicines. Iran J Pharm Res. 2015;14(2):345–6.Google Scholar
  2. 2.
    Bastani P, Dinarvand R, SamadBeik M, Pourmohammadi K. Pharmaceutical strategic purchasing requirements in Iran: Price interventions and the related effective factors. J Res Pharm Pract. 2016;5:35–42.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Koiek S, Gharib A. Iran’s healthcare system challenges at a glance. Chron Dis J. 2013;1(2):96–7.Google Scholar
  4. 4.
    Ashna Delkhosh R, Ali A. Salamzadeh J. decentralization and hospital pharmacy services: the case of Iranian University affiliated hospitals. Iran J Pharm Res. 2013;12:183–8.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Hayati R, Bastani P, Kabir MJ, Kavosi Z, Gh S. Scoping literature review on the basic health benefits package and its determinant criteria. Glob Health. 2018;14(1):26.CrossRefGoogle Scholar
  6. 6.
    Strategy for Pooled Procurement of Essential Medicines and Health Commodities, 2013-2017. available at See http://www.who.int/trade/glossary/story078/en/index.html [accessed 4 April 2013].
  7. 7.
    Bagheri LK, GhahramaniS HB. A study on hospitalized patients’ payment in south of Iran after the first round of health sector reform. Iran J Public Health. 2017;46(2):276–7.Google Scholar
  8. 8.
    Al-Abbadi I, Qawwas A, jaafreh M, Abosamen T, Saket M. One-year assessment of joint procurement of Pharmaceuticals in the Public Health Sector in Jordan. Clin Ther. 2009;31(6):1335–44.CrossRefPubMedGoogle Scholar
  9. 9.
    Bastani P, Mehralian G, Dinarvand R. Resource allocation and purchasing arrangements to improve accessibility of medicines: evidence from Iran. J Res Pharm Pract. 2015;4(1):9–17.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Moradi-Lakeh M, Vosoogh-Moghaddam A. Health sector evolution plan in Iran; equity and sustainability concerns. Int J Health Policy Manag. 2015;4(10):637–40.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Barati O, Dorosti H, Talebzadeh A, Bastani P. Accreditation status of hospital pharmacies and their challenges of medication management: a case of south Iranian largest university. J Adv Pharm Technol Res. 2016;7:70–4.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Bayati S, Bastani P, Sagheb ZM, Jamalabadi S, Samadbeik M. The performance implications of pharmacy information system at the university teaching hospitals of shiraz, Iran: cluster approach. J Adv Pharm Technol Res. 2017;8:125–30.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Luborsky MR, Rubinstein RL. Sampling in qualitative research: rationale, issues, and methods. Res Aging. 1995;17(1):89–113.Google Scholar
  14. 14.
    Bastani P, Samadbeik M, Dinarvand R, Kashefian-Naeeini S, Vatankhah S. Qualitative analysis of National Documents on health care services and pharmaceuticals` purchasing challenges: evidence from Iran. BMC Health Serv Res. 2018;18:410–9.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Pazirandeh A. Sourcing in global health supply chains for developing countries Literature review and a decision making framework. Int J Phys Distrib Logist Manag. 2011;41(4):364–84.CrossRefGoogle Scholar
  16. 16.
    Kirytopoulos K, Leopoulos V, Voulgaridou D. Supplier selection in pharmaceutical industry: an analytic network process approach. Benchmarking: An International Journal. 2008;15(4):494–516.  https://doi.org/10.1108/14635770810887267.
  17. 17.
    National Accounts of the Public Health Sector in Jordan. Amman, Jordan: Health Insurance Directorate; 2006.Google Scholar
  18. 18.
    Chaumont C, Bautista-Arredondo S, Calva JJ, Bahena-González RI, Sánchez-Juárez GH, González de Araujo-Muriel A, et al. Antiretroviral purchasing and prescription practices in Mexico: constraints, challenges and opportunities. Salud Publica Mex. 2015;57(2):171–82.CrossRefGoogle Scholar
  19. 19.
    Pooled Procurement of Medicines & Allied Commodities; Joint WHO, WIPO, WTO Technical Symposium Access to Medicines: Pricing and procurement practices -Zafar mirza, secretariat public health, Innovation and Intellectual Property; Geneva 16–20 July 2010.Google Scholar
  20. 20.
    Waning B, Maddix j, Soucy L. Research article balancing medicine prices and business sustainability: analyses of pharmacy costs, revenues and profit shed light on retail medicine mark-ups in rural Kyrgyzstan. BMC Health Serv Res. 2010;10:205–14.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Midliw P, Deierborg E, Holmdahl L, Höglund P, Eriksson T. Clinical outcomes from the use of medication report when elderly patients are discharged from hospital. Pharm World Sci. 2008;30(6):840–5.CrossRefGoogle Scholar
  22. 22.
    Imani A, Janati A, Moghimi M, Golestani M, Doshmangir L. Identification of indicators for evaluating the financial and economic performance of the pharmacy: a systematic review. Pharmaceutical Sciences. 2015;21:111–24.CrossRefGoogle Scholar
  23. 23.
    Arney L, Prashant Y, Roger M, Taylor W. Strategic contracting practices to improve procurement of health commodities. Glob Health Sci Pract. 2014;2(3):295–306.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  • Peivand Bastani
    • 1
  • Mohammad Hadi Imanieh
    • 2
  • Hesam Dorosti
    • 3
  • Reza Abbasi
    • 4
  • Seyyed Alireza Dashti
    • 5
  • Khosro Keshavarz
    • 1
    Email author
  1. 1.Health Human Resources Research Center, School of Management and Medical InformaticsShiraz University of Medical SciencesShirazIran
  2. 2.Department of Pediatric Gastroenterology, Gastroenterohepatology Research Center of Nemazee HospitalShiraz University of Medical SciencesShirazIran
  3. 3.Pharmaceutical Sciences Research Center, School of pharmacyShiraz University of Medical SciencesShirazIran
  4. 4.Student Research Committee CenterShiraz University of Medical SciencesShirazIran
  5. 5.Shiraz University of Medical SciencesShirazIran

Personalised recommendations